These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10128725)

  • 1. An evaluation of interventions designed to stimulate physician reporting of adverse drug events.
    Juergens JP; Szeinbach SL; Janssen MJ; Brown TR; Garner DD
    Top Hosp Pharm Manage; 1992 Jul; 12(2):12-8. PubMed ID: 10128725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of physicians identifying and reporting adverse drug events.
    Gatti JC
    Am Fam Physician; 2012 Feb; 85(4):318. PubMed ID: 22335311
    [No Abstract]   [Full Text] [Related]  

  • 3. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA Adverse Event Reporting System: Recruiting Doctors to Make Surveillance a Little Less Passive.
    Mann JM
    Food Drug Law J; 2015; 70(3):371-94, i. PubMed ID: 26630821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.
    Ehrenpreis ED; Sifuentes H; Ehrenpreis JE; Smith ZL; Marshall ML
    Expert Opin Drug Saf; 2012 Mar; 11(2):177-83. PubMed ID: 22316142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplements: physician knowledge and adverse event reporting.
    Cellini M; Attipoe S; Seales P; Gray R; Ward A; Stephens M; Deuster PA
    Med Sci Sports Exerc; 2013 Jan; 45(1):23-8. PubMed ID: 22811037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
    J Am Pharm Assoc (2003); 2012; 52(5):e109-12. PubMed ID: 23023857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician input: a critical strategic-planning tool.
    Rovinsky M
    Healthc Financ Manage; 2002 Jan; 56(1):36-8. PubMed ID: 11806316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of adverse drug event monitoring practices in U.S. hospitals.
    Juergens JP; Szeinbach SL
    Top Hosp Pharm Manage; 1992 Jul; 12(2):1-11. PubMed ID: 10128724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a comprehensive medication reaction reporting system.
    Yee WP; Norton LL; Catania HF
    Hosp Pharm; 1995 May; 30(5):384-5, 389-91, 394-6. PubMed ID: 10142377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.